Bold Prediction #7: The clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation “variant of uncertain significance (VUS)” obsolete.
Speakers:
Heidi Rehm, Ph.D., Broad Institute, Harvard Medical School & Massachusetts General Hospital
Douglas Fowler, Ph.D., University of Washington
Moderator:
Ben Solomon, M.D., NHGRI
-----------------------------------------
About the Seminar Series:
NHGRI hosts a seminar series on the “Bold Predictions for Human Genomics by 2030” that are described in NHGRI’s “Strategic Vision for Improving Human Health at the Forefront of Genomics.” Beginning in February 2021 — and coinciding with the 20th anniversary of the publication that reported the draft human genome sequence — this 10-part seminar series occurs approximately each month throughout 2021.
More: [ Ссылка ]
-----------------------------------------
Chapters:
0:00 - Introduction (Ben Solomon)
1:10- About the Bold Predictions Seminar Series
4:02 - Heidi Rehm Presentation
31:22 - Douglas Fowler Presentation
56:07 - Question and Answer session
